重新审视用于消除HIV感染的靶向毒素：你必须要有高效抗逆转录病毒治疗（HAART）。
Reconsidering targeted toxins to eliminate HIV infection: you gotta have HAART.
作者信息
Berger E A, Moss B, Pastan I
机构信息
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
出版信息
Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11511-3. doi: 10.1073/pnas.95.20.11511.
Abstract
The success of highly active anti-retroviral therapy (HAART) has inspired new concepts for eliminating HIV from infected individuals. A major obstacle is the persistence of long-lived reservoirs of latently infected cells that might become activated at some time after cessation of therapy. We propose that, in the context of treatment strategies to deliberately activate and eliminate these reservoirs, hybrid toxins targeted to kill HIV-infected cells be reconsidered in combination with HAART. Such combinations might also prove valuable in protocols aimed at preventing mother-to-child transmission and establishment of infection immediately after exposure to HIV. We suggest experimental approaches in vitro and in animal models to test various issues related to safety and efficacy of this concept.
摘要
高效抗逆转录病毒疗法（HAART）的成功激发了从感染个体中消除艾滋病毒的新观念。一个主要障碍是长期存在的潜伏感染细胞库，这些细胞在治疗停止后的某个时候可能会被激活。我们建议，在旨在故意激活并消除这些细胞库的治疗策略背景下，重新考虑将靶向杀死艾滋病毒感染细胞的杂合毒素与HAART联合使用。这种联合在旨在预防母婴传播以及在接触艾滋病毒后立即建立感染的方案中可能也被证明是有价值的。我们提出了体外和动物模型中的实验方法，以测试与这一观念的安全性和有效性相关的各种问题。
相似文献
1
Reconsidering targeted toxins to eliminate HIV infection: you gotta have HAART.重新审视用于消除HIV感染的靶向毒素：你必须要有高效抗逆转录病毒治疗（HAART）。
Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11511-3. doi: 10.1073/pnas.95.20.11511.
2
In vivo testing of anti-HIV immunotoxins.抗HIV免疫毒素的体内试验。
Methods Mol Biol. 2001;166:277-94. doi: 10.1385/1-59259-114-0:277.
3
Anti-HIV-1 immunotoxin 3B3(Fv)-PE38: enhanced potency against clinical isolates in human PBMCs and macrophages, and negligible hepatotoxicity in macaques.抗HIV-1免疫毒素3B3(Fv)-PE38：增强对人外周血单个核细胞和巨噬细胞中临床分离株的效力，且在猕猴中肝毒性可忽略不计。
J Leukoc Biol. 2006 Nov;80(5):1175-82. doi: 10.1189/jlb.0306139. Epub 2006 Aug 21.
4
Can HIV be Cured? Mechanisms of HIV persistence and strategies to combat it.艾滋病毒能被治愈吗？艾滋病毒持续存在的机制及对抗策略。
Curr HIV Res. 2004 Apr;2(2):99-111. doi: 10.2174/1570162043484915.
5
IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART.白细胞介素-7是一种强效且具有病毒株特异性的诱导剂，可诱导接受病毒抑制性高效抗逆转录病毒治疗（HAART）的感染者体内潜伏的HIV-1细胞储存库。
J Clin Invest. 2005 Jan;115(1):128-37. doi: 10.1172/JCI22574.
6
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.用于降低人类免疫缺陷病毒感染母婴传播风险的抗逆转录病毒药物。
Cochrane Database Syst Rev. 2007 Jan 24(1):CD003510. doi: 10.1002/14651858.CD003510.pub2.
7
Activation of latent HIV-1 expression by protein kinase C agonists. A novel therapeutic approach to eradicate HIV-1 reservoirs.蛋白激酶 C 激动剂激活潜伏的 HIV-1 表达。一种消除 HIV-1 储存库的新治疗方法。
Curr Drug Targets. 2011 Mar 1;12(3):348-56. doi: 10.2174/138945011794815266.
8
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.用于降低艾滋病毒感染母婴传播风险的抗逆转录病毒药物。
Cochrane Database Syst Rev. 2011 Jul 6(7):CD003510. doi: 10.1002/14651858.CD003510.pub3.
9
Influence of short-course antenatal antiretroviral therapy on viral load and mother-to-child transmission in subsequent pregnancies among HIV-infected women.短期产前抗逆转录病毒疗法对HIV感染女性后续妊娠中病毒载量及母婴传播的影响。
Antivir Ther. 2013;18(2):183-92. doi: 10.3851/IMP2327. Epub 2012 Aug 22.
10
Therapeutic potential of anti-HIV immunotoxins.抗HIV免疫毒素的治疗潜力。
Antiviral Res. 1996 Dec;33(1):1-9. doi: 10.1016/s0166-3542(96)00995-3.
引用本文的文献
1
Cell Proteins Interacting with the Human Immunodeficiency Virus in Immunoblotting can be Detected by R5- or X4- Tropic Human Immunodeficiency Virus Particles.在免疫印迹中与人类免疫缺陷病毒相互作用的细胞蛋白可通过R5或X4嗜性人类免疫缺陷病毒颗粒检测到。
Int J Appl Basic Med Res. 2020 Apr-Jun;10(2):81-85. doi: 10.4103/ijabmr.IJABMR_398_18. Epub 2020 Apr 2.
2
Curing HIV: lessons from cancer therapy.治愈 HIV：癌症疗法的启示。
Curr Opin HIV AIDS. 2013 May;8(3):224-9. doi: 10.1097/COH.0b013e32835ef0a1.
3
Towards an HIV cure: a global scientific strategy.迈向艾滋病治愈：全球科学策略。
Nat Rev Immunol. 2012 Jul 20;12(8):607-14. doi: 10.1038/nri3262.
4
Targeted cytotoxic therapy: adapting a rapidly progressing anticancer paradigm for depletion of persistent HIV-infected cell reservoirs.靶向细胞毒疗法：为清除持续性 HIV 感染细胞储库而调整快速发展的抗癌范式。
Curr Opin HIV AIDS. 2011 Jan;6(1):80-5. doi: 10.1097/COH.0b013e3283412515.
5
Immunotoxin complementation of HAART to deplete persisting HIV-infected cell reservoirs.高效抗逆转录病毒治疗（HAART）的免疫毒素互补作用以清除持续存在的HIV感染细胞储存库。
PLoS Pathog. 2010 Jun 10;6(6):e1000803. doi: 10.1371/journal.ppat.1000803.
6
Short communication: Activating stimuli enhance immunotoxin-mediated killing of HIV-infected macrophages.简短通讯：激活刺激增强免疫毒素介导的对HIV感染巨噬细胞的杀伤作用。
AIDS Res Hum Retroviruses. 2008 Nov;24(11):1399-404. doi: 10.1089/aid.2008.0082.
7
Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins.通过针对病毒蛋白的放射性标记抗体对病毒感染细胞进行靶向杀伤。
PLoS Med. 2006 Nov;3(11):e427. doi: 10.1371/journal.pmed.0030427.
8
Targeting therapeutics to an exposed and conserved binding element of the HIV-1 fusion protein.将治疗药物靶向于HIV-1融合蛋白一个暴露且保守的结合元件。
Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5016-21. doi: 10.1073/pnas.0936926100. Epub 2003 Apr 17.
本文引用的文献
1
Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection.在原发性HIV-1感染期间，潜伏感染的静止CD4(+) T细胞池的早期建立。
Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8869-73. doi: 10.1073/pnas.95.15.8869.
2
Toward HIV eradication or remission: the tasks ahead.迈向消除或缓解艾滋病毒：未来的任务。
Science. 1998 Jun 19;280(5371):1866-7. doi: 10.1126/science.280.5371.1866.
3
Viral dynamics in HIV-1 infection.HIV-1感染中的病毒动力学
Cell. 1998 May 29;93(5):665-71. doi: 10.1016/s0092-8674(00)81427-0.
4
Antiretroviral therapy for HIV infection: promises and problems.用于治疗HIV感染的抗逆转录病毒疗法：前景与问题
JAMA. 1998 May 6;279(17):1343-4. doi: 10.1001/jama.279.17.1343.
5
Exploring how to get at--and eradicate--hidden HIV.探索如何发现并消除隐藏的艾滋病毒。
Science. 1998 Mar 20;279(5358):1854-5. doi: 10.1126/science.279.5358.1854.
6
7
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.在高效抗逆转录病毒治疗期间存在可诱导的HIV-1潜伏库。
Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13193-7. doi: 10.1073/pnas.94.24.13193.
8
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.在接受高效抗逆转录病毒治疗的患者中鉴定HIV-1储存库。
Science. 1997 Nov 14;278(5341):1295-300. doi: 10.1126/science.278.5341.1295.
9
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.尽管血浆病毒血症长期受到抑制，但仍出现具有复制能力的HIV病毒的恢复。
Science. 1997 Nov 14;278(5341):1291-5. doi: 10.1126/science.278.5341.1291.
10
Effects of (R)-9-(2-phosphonylmethoxypropyl)adenine monotherapy on chronic SIV infection in macaques.（R）-9-（2-膦酰甲氧基丙基）腺嘌呤单一疗法对猕猴慢性猴免疫缺陷病毒感染的影响。
AIDS Res Hum Retroviruses. 1997 May 20;13(8):707-12. doi: 10.1089/aid.1997.13.707.
Zotero 插件